June saw five venture capital firms close new funds to back health care and life science companies, and Kleiner Perkins Caufield & Byers (KPCB) – one of the most prolific VC firms so far this year – disclosed in a June 29 US Securities and Exchange Commission (SEC) filing that it is raising at least $400m for its 17th fund.
Five of the top 10 most active venture capital investors in the US during the first half of 2016 are...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
